UBS Maintains Neutral on Molina Healthcare, Raises Price Target to $202

Benzinga Newsdesk www.benzinga.com Positive 58.6%

Neg 0% Neu 0% Pos 58.6%

UBS analyst A.J. Rice maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $180 to $202.